Ajanta Pharma USA Inc
Ajanta Pharma USA Inc appears in FDA public data with 2 recalls, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0611-2026, Class II) was initiated on May 28, 2026.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0611-2026 | Class II | Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, Ind | May 28, 2026 |
| D-0594-2026 | Class II | Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewat | May 27, 2026 |